Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

Sep 15, 2025 3:59:52 PM EDT

1.15USD-5.328%(-0.07)551,131

0.00Bid 0.00Ask 0.00Spread

Pre-market

Sep 15, 2025 9:27:30 AM EDT

1.18USD-3.279%(-0.04)14,368

After-hours

Sep 15, 2025 4:24:30 PM EDT

1.17USD+1.290%(+0.01)2,651

Overview HistoricalExchangesShortsMore

open chart

Market Cap

28.80M

Industry

Biotechnology

Next Earnings

Nov 26, 2025 (71d)

NRSN Stats

Avg. Vol. 10 Day

2,464,222

Avg. Vol. 30 Day

1,100,606

Employees

Market Cap

28,799,829

Shares Out.

25,043,330

On/Off Exchange

36%/64%

6 Month Beta

0.40

1 Year Beta

0.48

2 Year Beta

0.59

3 Year Beta

0.44

52 Week Low

0.80

52 Week High

2.60

SMA50

1.51

SMA200

1.32

1 Week

-0.86%

1 Month

-3.36%

3 Month

-53.06%

6 Month

-2.54%

1 Year

-14.18%

2 Year

+30.68%

5 Year

-71.54%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $1.15, and today's volume is 551,131. NRSN is down -5.328% today. The 30 day average volume is 1,100,606. NRSN market cap is 28.80M with 25,043,330 shares outstanding.

.dark-mode .rgV7k3{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .rgV7k3{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ